Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0001796789-26-000004

Options or other derivatives

  • Director acquired 22,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
George Jeffrey P. Director 2026-06-15 Grant or award · Stock Option (right to buy) +22,100 22,100 D: show line 1 in the form
Loading xslF345X06/wk-form4_1781569101.xml…